- Home
- HRMY vs YELP Comparison
HRMY vs YELP Comparison
Compare HRMY & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- YELP
- Stock Information
- Founded
- HRMY 2017
- YELP 2004
- Country
- HRMY United States
- YELP United States
- Employees
- HRMY N/A
- YELP N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- YELP Other Consumer Services
- Sector
- HRMY Health Care
- YELP Consumer Discretionary
- Exchange
- HRMY Nasdaq
- YELP Nasdaq
- Market Cap
- HRMY 2.0B
- YELP 2.3B
- IPO Year
- HRMY 2020
- YELP 2012
- Fundamental
- Price
- HRMY $34.50
- YELP $38.17
- Analyst Decision
- HRMY Strong Buy
- YELP Hold
- Analyst Count
- HRMY 8
- YELP 6
- Target Price
- HRMY $53.38
- YELP $34.00
- AVG Volume (30 Days)
- HRMY 751.0K
- YELP 804.9K
- Earning Date
- HRMY 05-06-2025
- YELP 05-08-2025
- Dividend Yield
- HRMY N/A
- YELP N/A
- EPS Growth
- HRMY 13.13
- YELP 32.33
- EPS
- HRMY 2.62
- YELP 2.05
- Revenue
- HRMY $744,852,000.00
- YELP $1,437,846,000.00
- Revenue This Year
- HRMY $20.35
- YELP $6.72
- Revenue Next Year
- HRMY $17.42
- YELP $4.58
- P/E Ratio
- HRMY $13.16
- YELP $18.58
- Revenue Growth
- HRMY 20.62
- YELP 5.93
- 52 Week Low
- HRMY $26.47
- YELP $32.29
- 52 Week High
- HRMY $41.61
- YELP $41.72
- Technical
- Relative Strength Index (RSI)
- HRMY 58.40
- YELP 54.09
- Support Level
- HRMY $33.47
- YELP $37.34
- Resistance Level
- HRMY $35.35
- YELP $39.58
- Average True Range (ATR)
- HRMY 1.13
- YELP 0.83
- MACD
- HRMY -0.10
- YELP -0.12
- Stochastic Oscillator
- HRMY 42.41
- YELP 21.39
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About YELP Yelp Inc.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.